Antitumor activities of kushen flavonoids in vivo and in vitro

Journal of Chinese Integrative Medicine

Volumn 6, Issue 1, 2008, Pages 51-59

  Sun, Ming Yu ^a   Zuo, Jian ^b   Duan, Ji Feng ^b   Han, Jun ^c   Fan, Shi Ming ^b   Zhang, Wei ^b   Zhu, Li Fang ^b   Yao, Ming Hui ^d  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Hutchison Medipharma Ltd   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Antineoplastic agents; Flavones; Mice; Sophora flavescens

Indexed keywords

2' METHOXY KURARINONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; FLAVONOID; KURARINONE; NURKURARINONE; PLANT MEDICINAL PRODUCT; SOPHORA FLAVESCENS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; OPTIMAL DRUG DOSE; SARCOMA; TUMOR CELL DESTRUCTION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, LEWIS LUNG; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; FEMALE; FLAVONOIDS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, NUDE; SARCOMA 180; TUMOR CELLS, CULTURED;

EID: 38649103528     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20080111     Document Type: Article

References (24)

1. State Administration of Traditional Chinese Medicine, Chinese herbal medicine. Shanghai: Shanghai Scientific and Technical Publishers. 1999: 634-643. Chinese.
2. Kyogoku K, Hatayama K, Komatsu M. Constituents of Chinese crude drug "Kushen" (the root of Sophora flavescens Ait.). Isolation of five new flavonoids and formononetin. Chem Pharm Bull. 1973; 21(12): 2733-2738.
3. Zhao YY, Wang B, Lei LM, et al. Constituents of the flavonoids from the roots of Sophora flavescens. Zhi Wu Xue Bao. 1993; 35(4): 304-306.
4. Ryu SY, Kim SK, No Z, et al. A novel flavonoid from Sophora flavescens. Planta Med. 1996; 62 (4): 361-363.
5. Woo ER, Kwak JH, Kim HJ, et al. A new prenylated flavonol from the roots of Sophora flavescens. J Nat Prod. 1998; 61(01): 1552-1554.
6. Kuroyanagi M, Arakawa T, Hirayama Y, et al. Antibacterial and antiandrogen flavonoids from Sophora flavescens. J Nat Prod. 1999; 62(12): 1595-1599.
7. Kang TH, Jeong SJ, Ko WG, et al. Cytotoxic lavandulyl flavanones from Sophora flavescens. J Nat Prod. 2000; 63(5): 680-681.
8. Ko WG, Kang TH, Kim NY, et al. Lavandulyl flavonoids: a new class of in vitro apoptogenic agents from Sophora flavescens. Toxicol In Vitro. 2000; 14 (5): 429-433.
9. Ding PL, Chen DF, Bastow KF, et al. Cytotoxic isoprenylated flavonoids from the roots of Sophora flavescens. Helvetica Chimica Acta. 2004; 87 (10): 2574-2580.
10. Kim YK, Min BS, Bae KH. A cytotoxic constituent from Sophora flavescens. Arch Pharm Res. 1997; 20 (4): 342-345.
11. De Naeyer A, Vanden Berghe W, Pocock V, et al. Estrogenic and anticarcinogenic properties of kurarinone, a lavandulyl flavanone from the roots of Sophora flavescens. J Nat Prod. 2004; 67(11): 1829-1832.
12. Ha TJ, Yang SY, Jang DS, et al. Inhibitory activities of flavanone derivatives isolated from Sophora flavescens for melanogenesis. Bull Korean Chem Soc. 2001; 22(1): 97-99.
13. Kang SS, Kim JS, Xu YN, et al. Isolation of a new cerebroside from the root bark of aralia elata. J Nat Prod. 1999; 62(7): 1059-106.
14. Chung MY, Rho MC, Ko JS, et al. In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens. Planta Med. 2004; 70(3): 258-260.
15. Carmichael J, Mitchell JB, DeGraff WG, et al. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer. 1988; 57(6): 540-547.
16. Bissery MC, Guénard D, Guéritte-Voegelein F, et al. Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a Taxol analogue. Cancer Res. 1991; 51(18): 4845-4852.
17. Xu SY, Bian RL, Chen X. Pharmacological experimental methods. 3rd ed. People's Medical Publishing House. 2002: 1762. Chinese.
18. Sancéau J, Poupon MF, Delattre O, et al. Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamid. Oncogene. 2002; 21(50): 7700-7709.
19. Hoi SU, Kim KH, Choi EJ, et al. P-glycoprotein (Pgp) does not affect the cytotoxicity of flavonoids from Sophora flavescens, which also have no effects on Pgp action. Anticancer Res. 1999; 19(3): 2035-2040.
20. Zhang LP, Jiang JK. Study of matrine on proliferation and differentiation of K562 cell line. Zhonghua Xue Ye Xue Za Zhi. 1999; 20(6): 315-316. Chinese.
21. Zhou BG, Sun JZ, So G, et al. Apoptosis of human breast cancer MCF-7 cells induced by oxymatrine. Zhonghua Shi Yan Wai Ke Za Zhi. 2002; 18(6): 689-691. Chinese with abstract in English.
22. Li LJ, Chen ZQ, Zheng YY, et al. Effects of oxymatrine on human ovarian cancer cell SKOV-3 in vitro. Shi Yong Zhong Liu Xue Za Zhi. 2003; 17 (2): 100-101. Chinese.
23. Wang YS. Chinese herbal drug pharmacology and application. Beijing: People's Medical Publishing House. 1983: 638. Chinese.
24. Li XR. Effects of 7 alkaloids from Kudouzi on immune function in mice. Zhong Cao Yao. 1987; 18(5): 22-23. Chinese.